News for 'Sun Pharmaceutical Industries and Ranbaxy Laboratories'

Sensex gains 65 points; Nifty ends above 8,100

Sensex gains 65 points; Nifty ends above 8,100

Rediff.com12 Sep 2014

The top gainers on the Sensex were Cipla, Bharti Airtel, Maruti Suzuki, Hero Moto & Sesa Sterlite.

Drugmakers draw more FDA scrutiny as US imports rise

Drugmakers draw more FDA scrutiny as US imports rise

Rediff.com13 Sep 2013

And when an inspector asked about the contents of unlabelled vials in the laboratory glassware washing area, a plant worker dumped them down a sink and said the contents could not be determined, according to a July 18 letter from the US Food and Drug Administration to Wockhardt, which makes sterile injectable drugs and various forms of insulin.

Pharma crusader takes India's drug regulators to court

Pharma crusader takes India's drug regulators to court

Rediff.com7 Mar 2016

Dinesh Thakur is famous for exposing Ranbaxy safety problems

3 Indian pharma firms named in US Congress price probe

3 Indian pharma firms named in US Congress price probe

Rediff.com9 Oct 2014

Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

Rediff.com21 Oct 2014

On October 2, a legislature committee wrote letters to the 14 companies, initiating an investigation and seeking details about recent price increases in several generic products available in the American market.

Sensex gains on Fed rally; posts best week since mid-June

Sensex gains on Fed rally; posts best week since mid-June

Rediff.com9 Oct 2015

Sensex, Nifty put up a good show in closing trade.

Earnings of Sensex companies: March to be best in 7 quarters

Earnings of Sensex companies: March to be best in 7 quarters

Rediff.com11 Apr 2016

Combined net profit estimated to grow 14.6% year-on-year, against a 5.7% decline in the Dec 2015 quarter

How the private sector has stalled India's reforms

How the private sector has stalled India's reforms

Rediff.com9 Jul 2018

'The failures of private businessmen have set back the process of market-oriented reform, though that is the only way forward,' argues T N Ninan.

FDA raises concern over US unit: Wockhardt

FDA raises concern over US unit: Wockhardt

Rediff.com28 May 2014

Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.

Sensex ends in the red amid volatile trade; IT, auto, realty fall

Sensex ends in the red amid volatile trade; IT, auto, realty fall

Rediff.com24 Mar 2015

The 30-share Sensex ended down 30.30 points at 28,161.72 and the 50-share Nifty dipped 7.95 points at 8,543.

Sensex, Nifty post biggest single-day fall in 2 months

Sensex, Nifty post biggest single-day fall in 2 months

Rediff.com9 Mar 2015

The 30-share Sensex ended down 604 points at 28,845 and the 50-share Nifty ended down 181 points at 8,757. The Bank Nifty ended down 602 points at 19,146.

Keep us in loop before any FDA swoop, India tells US

Keep us in loop before any FDA swoop, India tells US

Rediff.com11 Feb 2014

Inspections only in domestic authorities' presence, visiting US drug regulator told

FDI reforms: Now, pharma in focus

FDI reforms: Now, pharma in focus

Rediff.com18 Jul 2013

FDI in brownfield investment has resulted in acquisition of domestic drug-manufacturing firms by multinational companies.

Sensex marks lowest close in 10 weeks; power trips, IT, auto up

Sensex marks lowest close in 10 weeks; power trips, IT, auto up

Rediff.com25 Mar 2015

The 30-share Sensex ended 50 points lower at 28,112 and the 50-share Nifty declined 12 points to close at 8,531.

Markets snap 2-day losing streak; Nifty ends above 8,400

Markets snap 2-day losing streak; Nifty ends above 8,400

Rediff.com20 Nov 2014

Shares of ING Vysya Bank and Kotak Mahindra Bank rallied by up to 6% on the BSE on reports that Kotak Mahindra Bank in final stages to buy the bank.

Twenty-five essential drugs to see 90% decline in prices

Twenty-five essential drugs to see 90% decline in prices

Rediff.com6 Jul 2013

The latest price revision includes mostly cardiovascular drugs, anti-bacterials, anti-herpes, contraceptives and gastrointestinal medicines

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

Rediff.com6 Dec 2018

Sun Pharma's market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a piece - lowest since March 2013.

Indian drug cos to benefit as US expedites generic clearances

Indian drug cos to benefit as US expedites generic clearances

Rediff.com12 May 2014

Even smaller companies like Torrent Pharma and Alembic file five to 10 ANDAs every year.

Billionaire Club: India's 100 richest business tycoons

Billionaire Club: India's 100 richest business tycoons

Rediff.com16 Feb 2016

A majority of India's billionaires gained wealth in the last one year in spite of the stock market decline.

« Prev  |